ConductScience.org, home
Papers
API referenceFor AI assistants

Paper · 11031111

Characterization of a novel protein (FGFRL1) from human cartilage related to FGF receptors.

Wiedemann M and 1 other. Genomics, 2000. Cited by 130 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Characterization of a novel protein (FGFRL1) from human cartilage related to FGF receptors. Papers, record 11031111. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/11031111

On this page

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Characterization of a novel protein (FGFRL1) from human cartilage related to FGF receptors.
PubMed
Journal
Genomics
PubMed
Year
2000
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
130
iCite
Relative citation ratio, by iCite
2.2
iCite
Revised in PubMed
2006-11-15
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Wiedemann MM
2Trueb BB

Source PubMed

Topics13

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
CartilageMajor topic
Chromosomes, Human, Pair 4Major topic
Receptors, Fibroblast Growth FactorMajor topic
5' Untranslated Regions
Amino Acid Sequence
Exons
Gene Expression Profiling
Humans
Introns
Molecular Sequence Data
RNA Splicing
Receptor, Fibroblast Growth Factor, Type 5
Sequence Homology, Amino Acid

Source PubMed

Grants0

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

None in this release.

Trials0

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

None in this release.

Comments and corrections0

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

None in this release.

References0

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

None in this release.

Cited by74

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 130 citations.

PMIDTitleJournalYearIn PapersSource
42,429,045FGFR1 signaling in rheumatoid arthritis: Mechanisms of bone destruction and therapeutic targeting (Review).Int J Mol Med2026https://conductscience.org/library/papers/42429045PubMed
42,315,909Fibroblast growth factors in ischemic stroke: Therapeutic potential and clinical challenges.Acta Pharmacol Sin2026https://conductscience.org/library/papers/42315909PubMed
41,832,306FGF family in health and disease.Mol Biomed2026https://conductscience.org/library/papers/41832306PubMed
41,481,426FGFR Like1 drives esophageal cancer progression via EMT, PI3K/Akt, and notch signalling: insights from clinical data and next-generation sequencing analysis.FEBS Open Bio2026https://conductscience.org/library/papers/41481426PubMed
40,699,684FGFRL1: Structure, Molecular Function, and Involvement in Human Disease.Curr Issues Mol Biol2025https://conductscience.org/library/papers/40699684PubMed
39,665,319Targeting Fibrosis: From Molecular Mechanisms to Advanced Therapies.Adv Sci (Weinh)2025https://conductscience.org/library/papers/39665319PubMed
38,962,005Fibroblast growth factor signaling in macrophage polarization: impact on health and diseases.Front Immunol2024https://conductscience.org/library/papers/38962005PubMed
38,831,455Targeting FGFR for cancer therapy.J Hematol Oncol2024https://conductscience.org/library/papers/38831455PubMed
38,791,079Clinical Developments and Challenges in Treating FGFR2-Driven Gastric Cancer.Biomedicines2024https://conductscience.org/library/papers/38791079PubMed
38,045,829Oncofetal reprogramming in tumor development and progression: novel insights into cancer therapy.MedComm (2020)2023https://conductscience.org/library/papers/38045829PubMed

1 to 10 of 74

See all 74 cited by

Genes3

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
FGFRL153,834Swiss-Prot's referenceshttps://conductscience.org/library/genes/53834NCBI Gene
CDKN2A1,029PubTator's text mininghttps://conductscience.org/library/genes/1029NCBI Gene
FGFR32,261PubTator's text mininghttps://conductscience.org/library/genes/2261NCBI Gene

Drugs0

The drugs whose trials, in the Pipelines release, list the paper.

None in this release.

Data1

The data bank entries PubMed's record names. Trial numbers are under Trials.

Data bankAccession
GENBANKAJ277437

Source GENBANK

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/11031111

GET https://conductscience.org/api/papers/v1/11031111/cited_by?page=2

API referenceFor AI assistants